Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/79268
PIRA download icon_1.1View/Download Full Text
Title: Follow Your Virtual Trainer (FYVT): a randomised controlled trial protocol of IT-based lifestyle intervention programme to promote physical activity and health among middle-aged Hong Kong Chinese
Authors: Hui, SSC
Xie, YJ 
Kwok, RCW
Tam, EWC 
Mak, WWS
Mo, PKH
Issue Date: 2018
Source: BMJ open, May 2018, v. 8, no. 2, e017908, p. 1-9
Abstract: Introduction Hong Kong is a highly urbanised city where many people work long hours. The limited time and lack of professional instruction are the typical barriers to exercise. The purpose of this study is to test the effectiveness of an information technology-based lifestyle intervention programme on improving physical activity (PA) level and health status in a sample of middle-aged Hong Kong adults.
Methods and analysis A two-arm parallel randomised controlled trial named 'Follow Your Virtual Trainer' will be conducted among 200 physically inactive Chinese adults aged from 40 to 65 years. Those randomly allocated to an intervention group will be under the instruction of a web-based computer software termed `Virtual Trainer (VT)' to conduct a 3-month self-planned PA programme. A series of online seminars with healthy lifestyle information will be released to the participants biweekly for 3 months. After that, 6 months observation will follow. Those in the control group will only receive a written advice of standard PA recommendation and the textual content of the seminars. The assessments will be implemented at baseline, the 3rd, 6th and 9th months. The primary outcome is PA measured by accelerometer and International Physical Activity Questionnaire. The secondary outcomes include cardiorespiratory fitness, resting energy expenditure, anthropometrics, body composition, blood pressure, health-related quality of life, sleep quality and quantity, fatigue, behaviour mediators and maintenance of PA. The main effectiveness of the intervention will be assessed by a linear mixed model that tests the random effect of treatment on outcomes at the 3rd, 6th and 9th months.
Ethics and dissemination This trial has been approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (CRE 2015235). The study results will be presented at scientific conferences and published in peer-reviewed journals.
Publisher: BMJ Publishing Group Ltd
Journal: BMJ open 
EISSN: 2044-6055
DOI: 10.1136/bmjopen-2017-017908
Rights: This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
The following publication Hui, S. S. C., Xie, Y. J., Kwok, R. C. W., Tam, E. W. C., Mak, W. W. S., & Mo, P. K. H. (2018). Follow Your Virtual Trainer (FYVT): a randomised controlled trial protocol of IT-based lifestyle intervention programme to promote physical activity and health among middle-aged Hong Kong Chinese. BMJ open, 8(2), e017908, 1-9 is available at https://dx.doi.org/10.1136/bmjopen-2017-017908
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
Hui_Follow_Virtual_Trainer.pdf726.15 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

128
Last Week
1
Last month
Citations as of Mar 24, 2024

Downloads

97
Citations as of Mar 24, 2024

SCOPUSTM   
Citations

5
Last Week
0
Last month
Citations as of Mar 28, 2024

WEB OF SCIENCETM
Citations

4
Last Week
0
Last month
Citations as of Mar 28, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.